Skip to main content

Table 2 Comorbidities at baseline

From: BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study)

 

Total sample (n = 409)

Any comorbidity

65.5%

Depression

14.9%

Hypertension

9.3%

Obesity

7.3%

Anxiety

7.1%

Somnolence

6.6%

Extrapyramidal disorder

5.4%

Blood prolactin increased

5.1%

  1. Comorbidities that were present in at least 5% of the patients are shown. Some patients had multiple comorbidities, with one patient presenting with a total of 13 comorbidities
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us